We found a significant excess risk of mortality in the women <35 years, compared with the reference group of 50–69 years, in strata with traditionally good prognostic signs such as small tumour size, absence of lymphatic involvement and hormone receptor-positive tumours. The gene discussed is NR4A1; the disease is neoplasm.